Agreed that the May testing will be a positive update, but given the delays will it be enough to lift the stock significantly. It's been at least 10 months since the Mayo engagement was announced and, based on the small snippets of information that leak out, it's been at least 6 months since the prototype has been available. A Mayo announcement may be a case of too little too late.
Based on the glacial pace that this company moves, the UBand should be available about the time diabetes is cured using CRISPR technology. I've invested in several small caps and startups in the past but have never seen a technology with so much potential be obliterated through such slow execution.
News 
Market Data 
Discover 
